IBAB reports strong H1 2026 revenue and profitability growth
TradingView reports IBAB saw strong revenue and profitability growth in H1 2026, alongside robust proton therapy momentum.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.